𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical pharmacology of the hypocholesterolemic agent K 12.148 (lifibrol) in healthy volunteers

✍ Scribed by H. Hasibeder; H. J. Staab; K. Seibel; B. Heibel; G. Schmidle; W. März

Publisher
Springer
Year
1991
Tongue
English
Weight
560 KB
Volume
40
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical pharmacology of adinazolam and
Clinical pharmacology of adinazolam and N-desmethyladinazolam mesylate following single intravenous infusions of each compound in healthy volunteers
✍ J. C. Fleishaker; L. K. Hulst; T. C. Smith; H. Friedman 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 860 KB

The tolerability, pharmacokinetics and pharmacodynamics of adinazolam and N-desmethyladinazolam (NDMAD) were assessed following intravenous infusions of 5, 10, 15, and 20 mg adinazolam mesylate, 10, 20, 30 and 40 mg NDMAD mesylate, and placebo. Six subjects per dose level received treatments in a do

Clinical aspects of the apparent diffusi
Clinical aspects of the apparent diffusion coefficient in 3He MRI: Results in healthy volunteers and patients after lung transplantation
✍ Andrea Bink; Gorden Hanisch; Andrea Karg; Annette Vogel; Konstantinos Katsaros; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB

## Abstract ## Purpose To measure the apparent diffusion coefficient (ADC) after inhalation of hyperpolarized ^3^He in healthy volunteers and lung transplant recipients, and demonstrate the gravity dependence of ADC values. ## Materials and Methods Six healthy volunteers, 10 patients after singl